Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Sources include: the FDA Orange Book (for small molecules), the FDA Purple Book (for biologics, with awareness of its incompleteness), company 10-K and 10-Q filings (which disclose P.IV notices received and patent litigation), court dockets for pending Hatch-Waxman and BPCIA litigation, and third-party patent intelligence platforms that aggregate and analyze these data sources
Or a personalized GLP-1 injection may make more sense
Many bariatric specialists consider these medications when patients experience a weight loss plateau or early weight regain despite adherence to dietary and lifestyle recommendations
Another promising development is the investigation of Rybelsus's long-term benefits beyond glycemic control, including its impact on weight management, cardiovascular health, and the potential to modify the course of diabetes
